Biomarkers in cancer detection and monitoring of therapeutics. Volume 2, Diagnostic and therapeutic applications /
Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focu...
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
London, United Kingdom ; San Diego, CA :
Academic Press,
[2024]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Intro
- Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume 2: Diagnostic and Therapeutic Applications
- Copyright
- Contents
- Contributors
- Preface
- Chapter One: Oral squamous cell carcinoma
- 1. Oral cancer
- 2. Oral squamous cell carcinoma
- 3. Epidemiology
- 4. Etiology
- Impact of tobacco products
- Patterns and trends in tobacco use
- Use of smokeless tobacco products
- 5. Precursor lesions
- 5.1. Genetically acquired potentially malignant disorders
- 5.2. Tobacco-induced potentially malignant disorders
- 5.3. Immune-mediated potentially malignant disorders
- 5.4. Genetically inherited potentially malignant disorders
- 6. Oral epithelial dysplasia
- 7. Pathogenesis
- 7.1. Autophagy
- 8. Cancer stem cells
- 9. Tumor microenvironment
- 10. Epithelial-mesenchymal transition
- 11. Metastasis
- 12. Oral bacteria in oral carcinogenesis
- 13. Clinical features
- Salient features specific to subsite
- 14. Diagnosis
- 14.1. Adjunctive aids for early detection
- Nano-diagnostics
- Lab-on-chip/microfluidics
- Liquid biopsy
- Microarray technology
- Next generation sequencing
- Omics
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Staging of oral squamous cell carcinoma
- 15. Histopathological features
- 16. Treatment
- 16.1. Surgical resection
- Management of primary lesion
- Management of neck nodes
- 16.2. Chemotherapy
- Adjuvant chemotherapy
- Adjuvant chemoradiotherapy
- Primary chemoradiation
- Induction chemotherapy
- In the management of metastatic disease
- 16.3. Nanotechnology in carcinoma therapy
- Chemoprevention using nanoparticles
- 16.4. Radiotherapy
- 16.5. Immunotherapy
- Cytokines
- Toll-like receptors
- Immune checkpoint inhibitors
- Immune checkpoint activators
- 16.6. Therapeutic markers
- 17. Prognosis
- 17.1. Clinical factors
- 17.2. Histopathological factors
- 17.3. Metastasis
- References
- Chapter Two: Genetic predisposition and pathophysiology of oral squamous cell carcinoma
- 1. Introduction
- 1.1. Microbial flora
- 1.2. Oral microbial flora
- 1.3. Oral microbial flora and cancer
- 1.4. Squamous cell carcinoma of the head and neck
- 2. Oral squamous cell carcinoma and glucose transporters
- 2.1. Human glucose transporters
- 2.2. Glucose transporters (GLUT 1) and its expression
- 3. Oral squamous cell carcinoma and methylated genes
- 3.1. Variation of methylated genes in cancer conditions
- 3.2. DNA methylation modifications and its implications
- References
- Chapter Three: Molecular biomarkers in gastric cancer
- 1. Introduction
- 2. RNF43
- 3. APC
- 4. ARID1A
- 5. ARID2
- 6. MSI
- 7. MALTA1-GLT1 fusion
- 8. TP53
- 9. RB1
- 10. ERBB2
- 11. C-MET
- 12. EGFR
- 13. PD-L1
- 14. Epstein-Barr virus
- 15. VEGF-A
- 16. CD44
- 17. E-cadherin
- 18. Matrix metalloproteinases (MMPs)
- 19. Conclusions